CELLMIDI Logo
CELLMIDI
Who is CELLMIDI?

We are a preclinical-stage biotechnology spin-off company from Chulalongkorn University, focusing on the development of novel gene-edited immune cell products for cancer treatment.

Industry & Specialities
Others
Countries of Operation
Thailand

Headquarters:

Thailand

Company Type:

SME

Company size:

1-10 Employees

Year Founded:

2022 (4 years)

Address:

189/68 LADPRAO; 26 JOMPON JATUJAK; BANGKOK, BANGKOK 10900, TH


The largest company and people database for SEA & ANZ

Employees by Department

Key Decision Makers

Supannikar Fai Tawinwung
Chief Scientific Officer
Employees by Seniority
C-level
1employees
Senior
0employees
Non-managers
0employees

Financials

LOW

spending power

Funding Status
Private
Associated Legal Entities
0 entities
Ready to get started?
Start benefiting from our free-to-use platform today

Discover More Companies

Frequently Asked Questions (FAQ)

  • How long has CELLMIDI been operating for?
  • What is the funding status of CELLMIDI?
  • Where is CELLMIDI's headquarter?
  • What CELLMIDI's spending power?
  • Does CELLMIDI have a presence in the domain it operates in?

Get in touch